The big headline today is what appears to be BS ab
Post# of 1460
(Total Views: 483)
Posted On: 07/25/2018 8:39:01 PM
The big headline today is what appears to be BS about Biogen's amyloid plaque drug. This article deconstructs it well:
https://endpts.com/as-eisai-biogen-plot-a-cou...%20numbers
I note too that the crucial part of this drug's purported "success" is to get to patients very early. Well, unfortunately, most patients are not diagnosed 'very early."
Color me skeptical. I have much more hope for AVXL's possibility of success than in Biogen's drug actually being meaningful in the long term.
https://endpts.com/as-eisai-biogen-plot-a-cou...%20numbers
I note too that the crucial part of this drug's purported "success" is to get to patients very early. Well, unfortunately, most patients are not diagnosed 'very early."
Color me skeptical. I have much more hope for AVXL's possibility of success than in Biogen's drug actually being meaningful in the long term.
(1)
(0)Anavex Life Sciences Corp. (AVXL) Stock Research Links
Scroll down for more posts ▼